Aflatoxin B1 Induces Liver Injury by Disturbing Gut Microbiota-Bile Acid-Fxr Axis in Mice

Yunhuan Liu,Jinyan Li,Weili Kang,Shuiping Liu,Jinyan Liu,Mengdie Shi,Yubo Wang,Xianjiao Liu,Xingxiang Chen,Kehe Huang
DOI: https://doi.org/10.1016/j.fct.2023.113751
IF: 4.3
2023-01-01
Food and Chemical Toxicology
Abstract:Aflatoxin B1 (AFB1) is one of major pollutant in food and feed worldwide. The purpose of this study is to investigate the mechanism of AFB1-induced liver injury. Our results showed that AFB1 caused hepatic bile duct proliferation, oxidative stress, inflammation and liver injury in mice. AFB1 exposure induced gut microbiota dysbiosis and reduced fecal bile salt hydrolase (BSH) activity. AFB1 exposure promoted hepatic bile acid (BA) synthesis and changed intestinal BA metabolism, especially increased intestinal conjugated bile acids levels. AFB1 exposure inhibited intestinal farnesoid X receptor (FXR)/fibroblast growth factor 15 (FGF-15) signaling. Furthermore, the mice received fecal microbiota transplantation from AFB1-treated mice induced liver injury, reduced intestinal FXR signaling and increased hepatic BA synthesis. Finally, the intestine-restricted FXR agonist treatment decreased hepatic BA synthesis, ROS level, inflammation and liver injury in AFB1-treated mice. This study suggests that modifying the gut microbiota, altering intestinal BA metabolism and/or activating intestinal FXR/FGF-15 signaling may be of value for the treatment of AFB1-induced liver disease.
What problem does this paper attempt to address?